Navigation Links
New Weight-Loss Drug Shows Promise in Early Study
Date:1/8/2008

But adverse effects include gastrointestinal problems, anxiety

TUESDAY, Jan. 8 (HealthDay News) -- An experimental weight-loss drug helped people shed pounds, but its adverse effects included gastrointestinal distress and psychiatric problems, scientists report.

Called taranabant, the drug was developed by Merck Research Laboratories, which funded the new research published in the January issue of Cell Metabolism.

"It suppresses food intake and increases your metabolism," explained Dr. Steven Heymsfield, global director of scientific affairs, obesity, for Merck Research.

The drug works by blocking the same pleasure centers in the brain that are triggered when marijuana smokers get hungry. Blocking these cannabinoid receptors reduces hunger and helps people lose weight, the researchers said.

Taranabant is in the same class of drugs as rimonabant (Acomplia), which the U.S. Food and Drug Administration has not yet approved due to concerns about the risk of suicidal thoughts among some users. Rimonabant is on the market in Europe, however.

In the new study on taranabant, "no suicidal thoughts were reported," Heymsfield said. But the question was not asked, he added, in a systemic way. For a larger, upcoming trial, it will be, he noted.

In this latest study, Heymsfield's team assigned 533 obese patients to receive either a placebo or one of four taranabant doses: 0.5, 2, 4 or 6 milligrams daily. A total of 358 patients finished the 12-week study.

While the placebo group lost about 2.6 pounds during the study, the 6-milligram taranabant group lost the most.

"Those who took the 6-milligram dose every day for 12 weeks lost about 11 pounds," Heymsfield said. They also followed a reduced-calorie eating plan but had no specific exercise plan.

In a separate study reported by the same group of scientists in the journal, the researchers gave 36 overweight or obe
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. NutriSystem Advances Weight-Loss Category
2. Studies Examine Life After Weight-Loss Surgery
3. Psychiatric Woes Can Postpone Weight-Loss Surgery
4. FTC Attacks Infomercial Marketer to Silence Best-Selling Authors Weight-Loss Tips
5. UMass Medical School study identifies the best weight-loss plans for heart health
6. Weight-Loss Surgeries Extend Lives
7. Shorter HCV treatment shows notable success
8. DNC: Rudy Shows Again Hes Out-of-Touch With Americas Priorities
9. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
10. Twins study shows genetic basis for face and place recognition
11. Fetal surgeon shows for first time that laser procedure may treat vasa previa
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Weight-Loss Drug Shows Promise in Early Study
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a ... programs for advanced education in the field of dentistry, Spear ... As a visiting faculty member of this prestigious institution, Dr. ... he visits Spear Education to participate in a specialized workshop. ... training only the top 10% and those willing to sacrifice ...
(Date:3/6/2015)... 06, 2015 Medical Products, Inc., a ... agreement with GE Healthcare to become an authorized distributor ... States. , MPI has 31 years in distribution within ... , With this agreement, MPI will have the opportunity ... healthcare industry. , MPI has always strived to ...
(Date:3/6/2015)... 06, 2015 The Public Health ... five-year accreditation status to seven more health departments. This ... 1.3 million people can now be assured that their ... the health of their communities. , Public health departments ... health of people and communities. Across the nation, health ...
(Date:3/5/2015)... In 2014, the FDA approved 44 ... the list scoring 4 drug approvals in the USA. ... FDA approved drug products, followed by oncology therapy with ... anti-PD1 and CDK inhibitors keep on attracting large-cap pharmacos. ... to treat metastatic melanoma, and at present, they are ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... first time in more than a decade. She has hinted ... not want to miss seeing her perform one last time. ... two years and this beloved country sweetheart has millions of loyal ... be touring throughout her native country, Canada, and on June 30th ...
Breaking Medicine News(10 mins):Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... way to foil a tumor from generating blood vessels to ... by creating drugs aimed at stopping a key vessel growth-promoting ... , Researchers at the Moores Cancer Center at the University ... evidence that blocking that protein target, called VEGF, or vascular ...
... LegalView informed its readers of serious drug reactions and fatalities, which ... known as Heparin. The drug, from Baxter Healthcare, was found to ... ... Denver (PRWEB) November 9, 2008 -- LegalView.com, the number one ...
... #283-285, Ernest N. Morial Convention Center) , A team of ... key proteins out of thousands secreted into blood draining from ... quantities form the basis of a far more accurate early ... in people with severely reduced blood flow, or ischemia. ...
... they could cause interference when placed too closely to ... Tucking the headphones for your iPod into your coat ... interfere with the normal functioning of your implanted cardiac ... the American Heart Association,s annual scientific sessions, in New ...
... 57 percent less likely than Caucasian patients to ... year after successful angioplasty, a type of percutaneous ... coronary arteries. Hispanics also had a trend ... including stenting and bypass surgery, according to a ...
... release is available in French . ... international researchers including scientists from the McGill University ... that having high levels of particular protein puts patients ... of the study were so conclusive that the clinical ...
Cached Medicine News:Health News:Cancer drugs my build and not tear down blood vessels 2Health News:Cancer drugs my build and not tear down blood vessels 3Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 2Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 3Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 4Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 2Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 3Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 4Health News:MP3 Player Headphones May Throw Off Cardiac Devices 2Health News:MP3 Player Headphones May Throw Off Cardiac Devices 3Health News:Hispanics less likely to have repeat revascularizations 1 year after angioplasty 2Health News:Researchers discover new risk factor for cardiovascular disease, and a way to control it 2
(Date:3/5/2015)...  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... the approved abbreviated new drug application ("ANDA") for ... previously marketed by Teva Pharmaceuticals.  According to IMS ... approximately $39 million in 2014.   ... of ANI Pharmaceuticals, stated, "This acquisition further expands ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) has ... 2015: Year to Watch out for Authorized Generics (AGs), ... offering. The new pricing system adopted ... (Annexure 1) is a game changer initiative. It pains ... The most of the companies are revalidating their domestic ...
(Date:3/5/2015)... 2015 Hitachi Medical Systems ... OASIS *    at ECR 2015 - the ... set a benchmark for patient-centric care. The new features ... whilst optimizing workflow management and costs. OASIS demonstrates the ... for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
... , VIENNA, Va. , Feb. 16 /PRNewswire-FirstCall/ -- ... results for the quarter ended December 31, 2009 . , CEL-SCI ... December 31, 2009 was $19,159,517 versus a loss of ... income per share, basic was $0.10 for the quarter ended ...
... , , MIAMI , ... now have access to high-level, FDA support services at ... International) has pioneered a "Virtual GMP Consulting" service.  Through ... collaboration software, Pharmaceutical manufacturers now have access to GMP ...
Cached Medicine Technology:CEL-SCI Corporation Reports First Quarter 2010 Financial Results 2CEL-SCI Corporation Reports First Quarter 2010 Financial Results 3CEL-SCI Corporation Reports First Quarter 2010 Financial Results 4CEL-SCI Corporation Reports First Quarter 2010 Financial Results 5VPCI Pioneers 'Virtual GMP Consulting' for FDA Pharmaceutical Manufacturers 2
... flexible continuous monitoring, the M3 and M4 ... and neonatal patient care. M Series monitors ... includes a basic set of non-invasive parameters ... Optional Multi-Measurement Server extensions offer Mainstream or ...
... the patients side and in transit., ... measurements in a compact package to match ... care, lower acuity environments, and patient transfer., ... patient monitoring, the IntelliVue MP20 Junior has ...
Compact networked patient monitors for flexible care....
... High-performance monitoring for flexible care settings., ... monitors combine portability and measurement flexibility ... needs of intermediate care environmentsat the ... strong heritage in patient monitoring, IntelliVue ...
Medicine Products: